Sökning: WFRF:(Grams Morgan) >
Candidate Surrogate...
-
Grams, Morgan EJohns Hopkins University School of Medicine, Baltimore, Maryland, USA
(författare)
Candidate Surrogate End Points for ESRD after AKI
- Artikel/kapitelEngelska2016
Förlag, utgivningsår, omfång ...
-
American Society of Nephrology,2016
-
electronicrdacarrier
Nummerbeteckningar
-
LIBRIS-ID:oai:DiVA.org:liu-129985
-
https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-129985URI
-
https://doi.org/10.1681/ASN.2015070829DOI
Kompletterande språkuppgifter
-
Språk:engelska
-
Sammanfattning på:engelska
Ingår i deldatabas
Klassifikation
-
Ämneskategori:ref swepub-contenttype
-
Ämneskategori:art swepub-publicationtype
Anmärkningar
-
Funding agencies: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [K08DK092287]; National Kidney Foundation; National Institutes of Health/NIDDK [R01DK100446, R01DK096920]; Department of VA, Veterans Health Administration, Office of Research and De
-
AKI, a frequently transient condition, is not accepted by the US Food and Drug Association as an end point for drug registration trials. We assessed whether an intermediate-term change in eGFR after AKI has a sufficiently strong relationship with subsequent ESRD to serve as an alternative end point in trials of AKI prevention and/or treatment. Among 161,185 United States veterans undergoing major surgery between 2004 and 2011, we characterized in-hospital AKI by Kidney Disease Improving Global Outcomes creatinine criteria and decline in eGFR from prehospitalization to postdischarge time points and quantified associations of these values with ESRD and mortality over a median of 3.8 years. An eGFR decline of ≥30% at 30, 60, and 90 days after discharge occurred in 3.1%, 2.5%, and 2.6%, of survivors without AKI and 15.9%, 12.2%, and 11.7%, of survivors with AKI. For patients with in-hospital AKI compared with those with no AKI and stable eGFR, a 30% decline in eGFR at 30, 60, and 90 days after discharge demonstrated adjusted hazard ratios (95% confidence intervals) of ESRD of 5.60 (4.06 to 7.71), 6.42 (4.76 to 8.65), and 7.27 (5.14 to 10.27), with corresponding estimates for 40% decline in eGFR of 6.98 (5.21 to 9.35), 8.03 (6.11 to 10.56), and 10.95 (8.10 to 14.82). Risks for mortality were smaller but consistent in direction. A 30%-40% decline in eGFR after AKI could be a surrogate end point for ESRD in trials of AKI prevention and/or treatment, but additional trial evidence is needed.
Ämnesord och genrebeteckningar
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Sang, YingyingDepartments of Epidemiology, Baltimore, Maryland, USA
(författare)
-
Coresh, JosefDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
(författare)
-
Ballew, Shoshana HDepartments of Epidemiology, Baltimore, Maryland, USA
(författare)
-
Matsushita, KunihiroDepartments of Epidemiology, Baltimore, Maryland, USA
(författare)
-
Levey, Andrew SDepartments of Epidemiology, Baltimore, Maryland, USA
(författare)
-
Greene, Tom HDivision of Clinical Epidemiology, University of Utah School of Medicine, Salt Lake City, Utah, USA
(författare)
-
Molnar, Miklos ZDivision of Nephrology, University of Tennessee Health Science Center, Memphis, Tennessee, USA
(författare)
-
Szabó, ZoltánLinköpings universitet,Avdelningen för kardiovaskulär medicin,Medicinska fakulteten,Region Östergötland, Thorax-kärlkliniken i Östergötland(Swepub:liu)zolsz65
(författare)
-
Kalantar-Zadeh, KamyarUniversity of California Irvine Medical Center, Irvine, California, USA
(författare)
-
Kovesdy, Csaba PUniversity of Tennessee Health Science Center, Memphis, Tennessee, USA
(författare)
-
Johns Hopkins University School of Medicine, Baltimore, Maryland, USADepartments of Epidemiology, Baltimore, Maryland, USA
(creator_code:org_t)
Sammanhörande titlar
-
Ingår i:Journal of the American Society of Nephrology: American Society of Nephrology27:9, s. 2851-28591046-66731533-3450
Internetlänk
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Grams, Morgan E
-
Sang, Yingying
-
Coresh, Josef
-
Ballew, Shoshana ...
-
Matsushita, Kuni ...
-
Levey, Andrew S
-
visa fler...
-
Greene, Tom H
-
Molnar, Miklos Z
-
Szabó, Zoltán
-
Kalantar-Zadeh, ...
-
Kovesdy, Csaba P
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
- Artiklar i publikationen
-
Journal of the A ...
- Av lärosätet
-
Linköpings universitet